Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $500.61 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $255.30 | 10 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $101.07 | 3 | $0 (2020) |
| Lundbeck LLC | $61.00 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $34.75 | 3 | $0 (2019) |
| Boston Scientific Corporation | $16.29 | 1 | $0 (2022) |
| Alkermes, Inc. | $16.15 | 1 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $16.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.29 | 1 | Boston Scientific Corporation ($16.29) |
| 2021 | $16.15 | 1 | Alkermes, Inc. ($16.15) |
| 2020 | $72.65 | 3 | Lundbeck LLC ($46.22) |
| 2019 | $315.13 | 14 | Allergan Inc. ($255.30) |
| 2018 | $65.61 | 2 | Neurocrine Biosciences, Inc. ($54.00) |
| 2017 | $14.78 | 1 | Lundbeck LLC ($14.78) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/10/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: CNS | ||||||
| 08/13/2020 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $34.12 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: NEUROLOGY | ||||||
| 02/12/2020 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Neuroscience | ||||||
| 08/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $104.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Neuroscience | ||||||
| 05/08/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 01/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $60.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROLOGY | ||||||
| 01/09/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Neuroscience | ||||||
| 02/22/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $54.00 | General |
| Category: NEUROLOGY | ||||||
| 02/03/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 18 | $1,365 | $462.45 |
| 2021 | 2 | 46 | 82 | $7,728 | $3,230 |
| 2020 | 3 | 59 | 93 | $11,552 | $4,440 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 18 | $1,365 | $462.45 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 38 | $4,404 | $1,973 | 44.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 44 | $3,324 | $1,257 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 37 | $4,374 | $1,911 | 43.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 14 | 14 | $3,920 | $1,341 | 34.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 42 | $3,258 | $1,187 | 36.4% |
About Dr. Siddeeqah Bilal, M.D
Dr. Siddeeqah Bilal, M.D is a Psychiatry healthcare provider based in Magnolia, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225234164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Siddeeqah Bilal, M.D has received a total of $500.61 in payments from pharmaceutical and medical device companies, with $16.29 received in 2022. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($500.61).
As a Medicare-enrolled provider, Bilal has provided services to 116 Medicare beneficiaries, totaling 193 services with total Medicare billing of $8,132. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Magnolia, MS
- Active Since 06/26/2007
- Last Updated 04/29/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225234164
Products in Payments
- VRAYLAR (Drug) $255.30
- INGREZZA (Drug) $101.07
- ABILIFY MAINTENA (Drug) $61.00
- SPRAVATO (Drug) $23.14
- General - Pain Management (Device) $16.29
- VIVITROL (Drug) $16.15
- Hetlioz (Drug) $16.05
- INVEGA SUSTENNA (Drug) $11.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.